Hirofumi Ohmura

Assistant professor

Kyushu University

Japan

Research Interests

Explore related searches

Professors in Japan Professors in Immunology Immunology professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Hirofumi Ohmura is an Assistant Professor at Kyushu University in Japan. His research focuses on cancer treatment strategies, including the role of immune checkpoint inhibitors in various malignancies and the impact of genomic alterations on therapy efficacy. Recent publications highlight his work on T cell responses in esophageal cancer and complications associated with cardiac tumors, along with advancements in liquid biopsies for solid tumors.

Articles (21)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (6)

Taichi Isobe

Kyushu University

JAPAN

View details

Takahiro Maeda

Professor

Kyushu University Graduate School of Medical Sciences

JAPAN

View details

Kenji Tsuchihashi

Assistant Professor

Kyushu University

JAPAN

View details

Eishi Baba

JAPAN

View details

Daisuke Kiyozawa

Kyushu University

JAPAN

View details

Koshi Mimori

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Hirofumi Ohmura

Research Interests

Explore related searches

Contact this professor

About

Articles (21)

Treatment of malignant primary cardiac tumors requires attention to cardiovascular complications: a single-center, retrospective study

Myocardial metastasis from ZEB1- and TWIST-positive spindle cell carcinoma of the esophagus: A case report

Liquid biopsy for breast cancer and other solid tumors: a review of recent advances

Case report: A rare case of triple negative breast cancer with development of acute pancreatitis due to dexamethasone during adjuvant chemotherapy.

Spatial dynamics of CD39<sup>+</sup>CD8<sup>+</sup> exhausted T cell reveal tertiary lymphoid structures-mediated response to PD-1 blockade in esophageal cancer.

Impact of Genomic Alterations on Efficacy of Trastuzumab Deruxtecan Against Human Epidermal Growth Factor Receptor-2–Positive Advanced Gastric Cancer

Lymphoproliferative Disorder in an Esophageal Cancer Patient Treated with Pembrolizumab

Trousseau’s Syndrome with Advanced Neuroendocrine Carcinoma of Colon: A Case Report

Preferential B cell differentiation by combined immune checkpoint blockade for renal cell carcinoma is associated with clinical response and autoimmune reactions

Survival outcomes including salvage therapy of adult head and neck para-meningeal rhabdomyosarcoma: a multicenter retrospective study from Japan.

Case Report: Resolution of remitting seronegative symmetrical synovitis with pitting edema during nivolumab therapy for gastric cancer

Dynamic Changes in Peripheral Systemic Immunity Markers During Chemotherapy in HER2-negative Advanced Breast Cancer

A case of malignant phyllodes tumor that responded to pazopanib and developed pneumothorax

IMPROVE bleeding score predicts major bleeding in advanced gastrointestinal cancer patients with venous thromboembolism

Improvement in recurring nivolumab-induced pneumonitis with repetitive administration of infliximab in a patient with head and neck cancer: A case report

Prominent PD-L1-positive M2 macrophage infiltration in gastric cancer with hyper-progression after anti-PD-1 therapy

Predictive impact of C-reactive protein to albumin ratio for recurrent or metastatic head and neck squamous cell carcinoma receiving nivolumab.

Thrombocytopenia Caused by Dexamethasone in a Patient with Colorectal Cancer

RNA N6-methyladenosine demethylase FTO regulates PD-L1 expression in colon cancer cells

OX40 and LAG3 are associated with better prognosis in advanced gastric cancer patients treated with anti-programmed death-1 antibody

Helper T cell-dominant tertiary lymphoid structures are associated with disease relapse of advanced colorectal cancer

Collaborators (6)

Taichi Isobe

Takahiro Maeda

Kenji Tsuchihashi

Eishi Baba

Daisuke Kiyozawa

Koshi Mimori

Make your next move.

Hirofumi Ohmura

Research Interests

Explore related searches

Contact this professor

About

Articles (21)

Treatment of malignant primary cardiac tumors requires attention to cardiovascular complications: a single-center, retrospective study

Myocardial metastasis from ZEB1- and TWIST-positive spindle cell carcinoma of the esophagus: A case report

Liquid biopsy for breast cancer and other solid tumors: a review of recent advances

Case report: A rare case of triple negative breast cancer with development of acute pancreatitis due to dexamethasone during adjuvant chemotherapy.

Spatial dynamics of CD39&lt;sup&gt;+&lt;/sup&gt;CD8&lt;sup&gt;+&lt;/sup&gt; exhausted T cell reveal tertiary lymphoid structures-mediated response to PD-1 blockade in esophageal cancer.

Impact of Genomic Alterations on Efficacy of Trastuzumab Deruxtecan Against Human Epidermal Growth Factor Receptor-2–Positive Advanced Gastric Cancer

Lymphoproliferative Disorder in an Esophageal Cancer Patient Treated with Pembrolizumab

Trousseau’s Syndrome with Advanced Neuroendocrine Carcinoma of Colon: A Case Report

Preferential B cell differentiation by combined immune checkpoint blockade for renal cell carcinoma is associated with clinical response and autoimmune reactions

Survival outcomes including salvage therapy of adult head and neck para-meningeal rhabdomyosarcoma: a multicenter retrospective study from Japan.

Case Report: Resolution of remitting seronegative symmetrical synovitis with pitting edema during nivolumab therapy for gastric cancer

Dynamic Changes in Peripheral Systemic Immunity Markers During Chemotherapy in HER2-negative Advanced Breast Cancer

A case of malignant phyllodes tumor that responded to pazopanib and developed pneumothorax

IMPROVE bleeding score predicts major bleeding in advanced gastrointestinal cancer patients with venous thromboembolism

Improvement in recurring nivolumab-induced pneumonitis with repetitive administration of infliximab in a patient with head and neck cancer: A case report

Prominent PD-L1-positive M2 macrophage infiltration in gastric cancer with hyper-progression after anti-PD-1 therapy

Predictive impact of C-reactive protein to albumin ratio for recurrent or metastatic head and neck squamous cell carcinoma receiving nivolumab.

Thrombocytopenia Caused by Dexamethasone in a Patient with Colorectal Cancer

RNA N6-methyladenosine demethylase FTO regulates PD-L1 expression in colon cancer cells

OX40 and LAG3 are associated with better prognosis in advanced gastric cancer patients treated with anti-programmed death-1 antibody

Helper T cell-dominant tertiary lymphoid structures are associated with disease relapse of advanced colorectal cancer

Collaborators (6)

Taichi Isobe

Takahiro Maeda

Kenji Tsuchihashi

Eishi Baba

Daisuke Kiyozawa

Koshi Mimori

Make your next move.

Spatial dynamics of CD39<sup>+</sup>CD8<sup>+</sup> exhausted T cell reveal tertiary lymphoid structures-mediated response to PD-1 blockade in esophageal cancer.